Pictet Asset Management (Switzerland)’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $50.4M | Sell |
429,428
-202,965
| -32% | -$23.8M | 0.06% | 289 |
|
|
2023
Q1 | $50.6M | Buy |
632,393
+6,414
| +1% | +$514K | 0.06% | 278 |
|
|
2022
Q4 | $49.6M | Sell |
625,979
-98,223
| -14% | -$7.78M | 0.07% | 274 |
|
|
2022
Q3 | $50.5M | Sell |
724,202
-20,904
| -3% | -$1.46M | 0.07% | 264 |
|
|
2022
Q2 | $48.9M | Buy |
745,106
+56,551
| +8% | +$3.71M | 0.07% | 280 |
|
|
2022
Q1 | $45.8M | Sell |
688,555
-12,848
| -2% | -$855K | 0.05% | 329 |
|
|
2021
Q4 | $49.1M | Buy |
701,403
+63,911
| +10% | +$4.47M | 0.05% | 339 |
|
|
2021
Q3 | $33.3M | Buy |
+637,492
| New | +$33.3M | 0.04% | 410 |
|